U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1989
116
Substance Class Protein
Created
by admin
on Sat Jun 26 18:11:49 UTC 2021
Edited
by admin
on Sat Jun 26 18:11:49 UTC 2021
Protein Sub Type
Sequence Type COMPLETE
Record UNII
E211KPY694
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
BOTULINUM TOXIN TYPE A
JAN   VANDF   WHO-DD  
Common Name English
BOTULINUM TOXIN TYPE A [WHO-DD]
Common Name English
BOTULINUM TOXIN TYPE A [VANDF]
Common Name English
ANT-1403
Code English
AGN-151607
Common Name English
BOTULINUM A TOXIN [MART.]
Common Name English
BOTULIN A [MI]
Common Name English
RT001 (BOTULINUM TOXIN A)
Code English
EC 3.4.24.69
Common Name English
BOTULIN A
MI  
Common Name English
ANT-1207
Code English
BOTULINUM TOXIN TYPE A [JAN]
Common Name English
BOTULINUM A TOXIN
MART.  
Common Name English
BOTULINUM TOXIN A
Common Name English
BTX-A
Common Name English
BOTULINUM NEUROTOXIN TYPE A (EC 3.4.24.69) FROM CLOSTRIDIUM BOTULINUM
Common Name English
ONACLOSTOX [HSDB]
Common Name English
RT-001 (BOTULINUM TOXIN A)
Code English
ANT-1401
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 483
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 35789
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NDF-RT N0000175771
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 114198
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 64591
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 56591
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 9885
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
FDA ORPHAN DRUG 128299
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NDF-RT N0000175770
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
NCI_THESAURUS C296
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
Code System Code Type Description
ECHA (EC/EINECS)
297-253-4
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
LACTMED
PrabotulinumtoxinA
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
MERCK INDEX
M2632
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY Merck Index
DRUG CENTRAL
5368
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
RXCUI
1712
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
FDA UNII
E211KPY694
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
CAS
93384-43-1
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
NCI_THESAURUS
C82623
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
EVMPD
SUB13117MIG
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
DRUG BANK
DB00083
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
LACTMED
Botulin A
Created by admin on Sat Jun 26 18:11:50 UTC 2021 , Edited by admin on Sat Jun 26 18:11:50 UTC 2021
PRIMARY
From To
1_6 2_429
1_787 1_832
Related Record Type Details
NX-01
INHIBITOR -> TARGET
RELABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
NX-11
INHIBITOR -> TARGET
ONABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
ABOBOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
DAXIBOTULINUMTOXIN A
SUB_CONCEPT->SUBSTANCE
NX-02
INHIBITOR -> TARGET
EVABOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
INCOBOTULINUMTOXINA
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
BOTULINUM TOXIN TYPE A
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966